Promoter Hemal Mehta of Sudarshan Pharma Industries has released the pledge on 20,00,000 equity shares, reducing his encumbered holding to zero. The un-pledge, which represents 0.83% of the company’s total share capital, was executed on August 6, 2026, and disclosed to the stock exchanges on August 8, 2026, under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This move removes all outstanding encumbrances from Mehta’s stake, potentially easing concerns regarding promoter liquidity and collateral risk for lenders and investors.

The disclosure, filed with BSE Limited, confirms that the shares were previously pledged in favor of Mr. Kirit Ratilal Shah. The original encumbrance was created due to a loan taken by the promoter for personal reasons. With the release of these shares, the number of encumbered shares held by Mehta has dropped from 20,00,000 to nil. There were no new pledges or liens created during this period.

Pledge Status Details

Mehta continues to hold a substantial stake of 6,40,21,020 shares, accounting for 26.60% of the total share capital. The release of the pledge indicates that the underlying loan obligation has been settled or restructured without requiring continued collateral against these specific shares.

What This Means

The complete removal of encumbrances from the promoter’s holding is a positive signal for corporate governance and financial stability. Promoter pledging is often viewed as a proxy for personal liquidity stress; when promoters pledge significant portions of their holdings, it raises the risk of forced sell-offs if the stock price declines or if margin calls are triggered by lenders. By clearing the pledge entirely, Mehta demonstrates improved financial flexibility. For investors, this reduces the overhang of potential dilution or distress sales associated with pledged stakes. The disclosure ensures transparency regarding the promoter’s leverage position, allowing market participants to assess the quality of the promoter’s holding more accurately.

Sudarshan Pharma Industries Limited disclosed that promoter Mr. Hemal Vasantrai Mehta has pledged 0.83% of the company's total share capital to secure a personal loan. The encumbrance involves 20,00,000 shares and was created on June 3, 2026, in favor of Mr. Kirit Ratilal Shah. This disclosure, submitted to BSE Limited, rectifies previous errors regarding post-event holding tallies and provides the specific reason for the pledge, which was initially omitted.

The revised filing addresses queries raised by the exchange regarding the original submission made on June 5, 2026. Specifically, the company corrected the format to comply with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as per the circular effective August 5, 2015. The document confirms that the pledge was a creation of encumbrance rather than a release or invocation.

Details of Encumbrance

The following table outlines the specifics of the share pledge disclosed by the promoter:

Prior to this event, the promoter had no encumbered shares. Following the creation of the pledge, the total number of encumbered shares stands at 20,00,000. The disclosure was signed by Hemal Mehta, Promoter, and countersigned by Nirav Shah, Company Secretary & Compliance Officer, on July 14, 2026.